The Canadian Advisory Council on the Implementation of National Pharmacare has issued a final report on proposed Pharmacare, saying that Canada should have a national program that is universal, single payer and public.
The Council, which was tasked last June to look into the issue, says this kind of program will result in better drug coverage for Canadians and save individuals and governments money. It also said that Canada’s national Pharmacare should include a national drug agency and formulary. It is chaired by former Ontario Liberal Health Minister Dr Eric Hoskins.
A universal, single-payer public Pharmacare will result in better value for money and substantial savings for governments, businesses, and individual Canadians. Once implemented, Pharmacare's stronger negotiating power, lower administrative costs, as well as other improvements will save taxpayers an estimated C$5 billion ($3.76 billion) annually.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze